Stroke Trials Registry

Tinzaparin
Innohep®

Action
Low molecular weight heparin

Status
Phase III trial ongoing 1999 for acute ischemic stroke.

Trial(s)
= Ongoing
= Completed

CATALIST Combination Anti-platelet and Anti-coagulation Treatment After Lysis of Ischemic Stroke Trial [SPOTRIAS]

TAIST Tinzaparin in Acute Ischemic Stroke Trial

Web Links and Publications

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Cochrane Review).
Cochrane Database Syst Rev. 2001;4:CD000119.

Atrial fibrillation, stroke, and acute antithrombotic therapy.
Stroke 2003 Mar;34(3):590-1

Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
Lancet. 2001 Sep 1;358(9283):702-10.

Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Ongoing Clinical Trials Session, 25th International Stroke Conference.
Ongoing Clinical Trials Session, 25th International Stroke Conference.

UID: 55